搜尋結果
The Muir, A New Luxury Waterfront Hotel In Halifax, Nova Scotia
Forbes· 1 日前Designed in the shape of a ship’s bow, the Muir juts out dramatically over Halifax harbor, the ...
Here are Thursday's biggest analyst calls: Nvidia, Tesla, Ford, Super Micro, Wendy's, ...
CNBC· 1 日前Here are the biggest calls on Wall Street on Thursday: Bernstein initiates Ford as outperform ...
Oxford Geoscience Professor Myles Allen On Solving The Problem Of Climate Change
Forbes· 2 日前Oxford Geoscience Professor Myles Allen is one of the world's leading climate scientists. In his Gresham Lecture he discusses ...
After 20 Years, ‘Paper Mario: The Thousand Year Door’ Reopens On Nintendo Switch
Forbes· 2 日前If you own a Nintendo Switch and have been hankering for some quasi-2D turn-based RPG action ...
A Nearby Planet Could Be Earth 2.0 Or An ‘Evil Twin,’ Say Scientists
Forbes· 2 日前A planet just 40 light-years from the solar system has been discovered to be tantalizingly ...
Rumors Swirl Around ‘Bennifer’: A Complete Jennifer Lopez and Ben Affleck Timeline—As Lopez ...
Forbes· 2 日前May 22Lopez was asked on Wednesday if the "rumors" about her and Affleck are true ...
和鉑醫藥(02142)與阿斯利康就腫瘤靶向療法訂許可協議 升19%
infocast via Yahoo財經香港· 2 日前和鉑醫藥(02142)公布,全資附屬諾納生物(蘇州),已就將用於創建腫瘤靶向療法的臨床前單克隆抗體與阿斯利康阿斯利康訂立許可及選擇權協議,根據協議,諾納生 ...
即時新聞 - 重要通告 - 和鉑醫藥與阿斯利康訂立新型腫瘤靶向療法許可 - 信報網站 hkej.com
信報· 2 日前和鉑醫藥(02142)公布,旗下全資附屬公司諾納生物(蘇州),已就將用於創建腫瘤靶向療法的臨床前單克隆抗 ...
和鉑醫藥-B(02142.HK)與阿斯利康訂立新型腫瘤靶向療法之許可及選擇權協議
AASTOCKS via Yahoo財經香港· 2 日前和鉑醫藥-B(02142.HK)公布,全資附屬諾納生物已就將用於創建腫瘤靶向療法的臨床前單克隆抗體,與阿斯利康(AZN.US)訂立許可及選擇權協議。根據協議,諾納生 ...
和鉑醫藥與阿斯利康訂立新型腫瘤靶向療法許可及選擇權協議
infocast via Yahoo財經香港· 2 日前和鉑醫藥(02142)宣布,公司全資附屬諾納生物(蘇州),已就將用於創建腫瘤靶向療法的臨床前單克隆抗體,與阿斯利康訂立許可及選擇權協議。根據協議,諾納生 ...